Tools & Calculators
Sector: Pharmaceuticals & Biotechnology
|Mid Cap
Corona Remedies Ltd.
₹1,577
₹1525.00
₹1595.00
₹1336.60
₹1660.80
Markets Today
Historical Performance
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|
| Total Revenue | 342.42 | 361.13 | 346.54 | 297.69 | 313.87 |
| Operating Expense | 259.26 | 282.66 | 276.76 | 228.27 | 247.05 |
| Operating Profit | 83.16 | 78.47 | 69.78 | 69.42 | 66.82 |
| Depreciation | 9.45 | 9.20 | 8.92 | 9.69 | 9.05 |
| Interest | 1.66 | 1.93 | 1.99 | 2.39 | 2.87 |
| Tax | 13.94 | 17.46 | 14.49 | 13.33 | 14.38 |
| Net Profit | 41.25 | 52.15 | 46.40 | 44.77 | 42.98 |
₹1577.00
↗ Bullish Moving Average
8
↘ Bearish Moving Average
1
| Held By | Dec 2025 |
|---|---|
| Promoter | 69 |
| FII | 1.8 |
| DII | 6.8 |
| Public | 22.4 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 4.95 K | 13.6 K | 36.43% |
| Week | 8.05 K | 18.22 K | 44.17% |
| 1 Month | 19.84 K | 48.04 K | 41.30% |
| 6 Month | 61.28 K | 1.99 L | 30.80% |
Positive Breakout First Resistance ( LTP > R1)
Relative Outperformance versus Industry over 1 Year
Growth Stars: Strongest Annual EPS Performers
Annual Profit Growth higher than Sector Profit Growth
Companies with Low Debt
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Near 52 Week High
Top Gainers
High Volume, High Gain
Volume Shockers
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| No Record Found | ||||
Financials | |||||
|---|---|---|---|---|---|
| Price (₹) | ₹628.95 | ₹780 | ₹968 | ₹1,320 | ₹4,075 |
| % Change | -5.40% | -0.01% | 2.83% | 3.96% | 0.75% |
| Revenue TTM (₹ Cr) | - | ₹1,598.19 | ₹2,169.86 | ₹1,419.33 | ₹798.10 |
| Net Profit TTM (₹ Cr) | - | ₹206.20 | ₹332.94 | ₹20.10 | ₹217.90 |
| PE TTM | - | 62.20 | 61.50 | 754.90 | 43.10 |
| 1 Year Return | 6.51 | 60.63 | 37.17 | 3.9 | -12.48 |
| ROCE | 34.78 | 34.76 | 12.51 | 3.26 | - |
Akums Drugs & Pharmaceuticals Ltd.
₹ 474.00
-0.91%
Blue Jet Healthcare Ltd
₹ 391.40
+9.99%
Concord Biotech Ltd.
₹ 1103.00
+0.46%
Aarti Pharmalabs Ltd.
₹ 687.60
-1.60%
Supriya Lifescience Ltd.
₹ 670.00
-1.17%
Acutaas Chemicals Ltd.
₹ 2138.50
+1.52%
Alivus Life Sciences Ltd.
₹ 901.15
-1.08%
Cohance Lifesciences Ltd.
₹ 315.10
+3.18%
Eris Lifesciences Ltd.
₹ 1358.00
+1.16%
Syngene International Ltd.
₹ 448.60
+1.33%
Alembic Pharmaceuticals Ltd.
₹ 774.90
+1.55%
Strides Pharma Science Ltd.
₹ 872.90
+0.37%
Granules India Ltd.
₹ 598.00
-0.18%
FDC Ltd.
₹ 383.00
+3.82%
Shilpa Medicare Ltd.
₹ 329.00
+1.29%
Jubilant Pharmova Ltd.
₹ 900.00
+3.15%
Natco Pharma Ltd.
₹ 886.00
-0.64%
Caplin Point Laboratories Ltd.
₹ 1739.00
+2.77%
Neuland Laboratories Ltd.
₹ 13507.00
+6.88%
Marksans Pharma Ltd.
₹ 179.32
+0.53%
Sanofi India Ltd.
₹ 4080.00
+1.34%
Procter & Gamble Health Ltd.
₹ 5080.00
+1.21%
Jeena Sikho Lifecare Ltd.
₹ 674.90
-2.16%
By signing up I certify terms, conditions & privacy policy